VIA
RGNX icon

Virtus Investment Advisers’s Regenxbio RGNX Stock Holding History

Virtus Investment Advisers’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
49,129
+29,469
+150% +$245K 0.14% 201
2026
Q1 		$165K Buy
19,660
+479
+2% +$5.03K 0.05% 437
2025
Q4 		$276K Buy
19,181
+8,026
+72% +$100K 0.08% 276
2025
Q3 		$108K Buy
11,155
+1,936
+21% +$17.1K 0.03% 418
2025
Q2 		$75.7K Sell
9,219
-9,611
-51% -$80.5K 0.03% 430
2025
Q1 		$135K Buy
+18,830
New +$140K 0.04% 366

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Virtus Investment Advisers's RGNX Position: Q2 2026 in Review

Virtus Investment Advisers increased its Regenxbio (RGNX) stake by 150% in Q2 2026, buying an estimated $245K and bringing the position to 49,129 shares worth $589K. The position accounts for 0.14% of the portfolio, ranked #201.

Virtus Investment Advisers first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Virtus Investment Advisers held 49,129 shares of Regenxbio worth $589K as of Q2 2026.
  • Virtus Investment Advisers bought 29,469 Regenxbio shares in Q2 2026, an estimated $245K.
  • Regenxbio made up 0.14% of Virtus Investment Advisers's portfolio in Q2 2026, its #201 holding.
  • Virtus Investment Advisers first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.